Page last updated: 2024-11-02

oxybutynin and Anxiety

oxybutynin has been researched along with Anxiety in 3 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.

Research Excerpts

ExcerptRelevanceReference
"We sought to evaluate the efficacy of using a quick response (QR) code within video education to guide proper use of fentanyl transdermal patches and control pain, depression, and anxiety levels in cancer patients."9.34Video Education Reduces Pain and Anxiety Levels in Cancer Patients Who First Use Fentanyl Transdermal Patch: A Randomized Controlled Trial. ( Chen, J; Hu, X; Mao, X; Rao, Y; Xuan, Z; Yang, S; Ye, Z; Zhang, Y, 2020)
"Six-months analysis of non-interventionally collected observation data of effectiveness of long-term treatment with low-dose 7-day buprenorphine transdermal patch in elderly patients with chronic pain."7.79[Long-term treatment of chronic pain with low-dose 7-day buprenorphine transdermal patch. Observational data from elderly patients of pain relief and quality of life]. ( Müller-Schwefe, GH; Uberall, MA, 2013)
"We sought to evaluate the efficacy of using a quick response (QR) code within video education to guide proper use of fentanyl transdermal patches and control pain, depression, and anxiety levels in cancer patients."5.34Video Education Reduces Pain and Anxiety Levels in Cancer Patients Who First Use Fentanyl Transdermal Patch: A Randomized Controlled Trial. ( Chen, J; Hu, X; Mao, X; Rao, Y; Xuan, Z; Yang, S; Ye, Z; Zhang, Y, 2020)
"Six-months analysis of non-interventionally collected observation data of effectiveness of long-term treatment with low-dose 7-day buprenorphine transdermal patch in elderly patients with chronic pain."3.79[Long-term treatment of chronic pain with low-dose 7-day buprenorphine transdermal patch. Observational data from elderly patients of pain relief and quality of life]. ( Müller-Schwefe, GH; Uberall, MA, 2013)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Akkoç, Y1
Bardak, AN1
Yıldız, N1
Özlü, A1
Erhan, B1
Yürü, B1
Öztekin, SNS1
Türkoğlu, MB1
Paker, N1
Yumuşakhuylu, Y1
Canbaz Kabay, S1
Ekmekçi, Ö1
Elbi, H1
Yüceyar, AN1
Ye, Z1
Chen, J1
Zhang, Y1
Hu, X1
Xuan, Z1
Yang, S1
Mao, X1
Rao, Y1
Uberall, MA1
Müller-Schwefe, GH1

Trials

1 trial available for oxybutynin and Anxiety

ArticleYear
Video Education Reduces Pain and Anxiety Levels in Cancer Patients Who First Use Fentanyl Transdermal Patch: A Randomized Controlled Trial.
    Drug design, development and therapy, 2020, Volume: 14

    Topics: Adult; Aged; Aged, 80 and over; Anxiety; Female; Fentanyl; Health Education; Humans; Male; Middle Ag

2020

Other Studies

2 other studies available for oxybutynin and Anxiety

ArticleYear
The relationship between severity of overactive bladder symptoms and cognitive dysfunction, anxiety and depression in female patients with multiple sclerosis: Running head: OAB-V8, BICAMS and HAD scale in MS.
    Multiple sclerosis and related disorders, 2023, Volume: 70

    Topics: Adolescent; Anxiety; Child; Child, Preschool; Cognitive Dysfunction; Depression; Female; Humans; Mul

2023
[Long-term treatment of chronic pain with low-dose 7-day buprenorphine transdermal patch. Observational data from elderly patients of pain relief and quality of life].
    MMW Fortschritte der Medizin, 2013, Oct-10, Volume: 155 Suppl 3

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Anxiety; Buprenorphine; Chronic Pain; Depressio

2013